Friday, May 17, 2024
11:15 AM EST – XORTX Therapeutics Inc. : Announces that it has received TSX Venture Exchange approval to amend the terms of the balance of outstanding common share purchase warrants that were issued on October 15, 2021. XORTX Therapeutics Inc. (V.XRTX) shares were unchanged at 3.35.
Stocks in Play: XORTX Therapeutics Inc., Fri, 17 May 2024 11:27:05 EST